This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

WINSTON-SALEM, N.C. — The manufacture of EpiPen, Mylan Pharmaceutical, is coming under fire for price gouging. Some lawmakers are calling for a probe into the company after they’ve raised the price from around $50 in 2007 to more than $500 today.

“We really can’t tell a difference that would warrant such a price increase,” said pharmacist Ryan Hoskins, of Archdale Drug. “We’ve heard nothing as far as why from the manufacturer.”

And neither has Tracy Bush, of Pfafftown, a nutritionist whose 14-year-old suffers from allergies. She has been speaking out on national news networks about Mylan’s price increase.

“As a family that has to get several EpiPen twin packs each year for back to school, had I not had insurance it would have been a cost of $1,800 out of pocket for three twin packs,” Bush told Fox Business Channel Monday.

The manufacturer has yet to comment on the scrutiny, especially after fillings show the CEO Heather Bresch’s salary went up from $2.4 million to $18.9 million during the same time the EpiPen skyrocketed.

“We don’t all have a lot of money to spend on lifesaving devices,” said Bush. “You shouldn’t have to put a price on your child’s or your family members’ or your own life at the end of the day.”

The company does have an assistant program that will knock $100 off the $500 device.